# Prophylaxis of Venous Thromboembolism After Bariatric Surgery

> **NCT02295150** · PHASE4 · UNKNOWN · sponsor: **Rijnstate Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Morbid Obesity
- Thromboembolism
- Bypass Complications

## Interventions

- **DRUG:** Nadroparin

## Key facts

- **NCT ID:** NCT02295150
- **Lead sponsor:** Rijnstate Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2014-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02295150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02295150, "Prophylaxis of Venous Thromboembolism After Bariatric Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02295150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*